About Bacillus (soil-based species)
Consolidated entry for the minor soil-based (spore-forming) Bacillus species used in multi-strain products (amyloliquefaciens, megaterium, pumilus, indicus/HU36, polymyxa, licheniformis). These appear mainly in soil-based/'MegaSpore'-style blends; isolated human efficacy data is thin to absent. B. subtilis, B. clausii and B. coagulans are stronger and have their own entries. Graded low.
What Bacillus (soil-based species) supports
- Spore-forming; shelf- and acid-stable blend components
- Limited isolated clinical evidence at the species level
How much Bacillus (soil-based species) to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
1–5
billion_cfu
No established species-specific therapeutic dose; spore-forming, typically 1-5 billion CFU/day as blend components. Presence-only; nominal range.
Clinical evidence
Limited clinical evidence. Low: minor soil Bacillus species, sparse isolated evidence.
Examine.com